0001104659-23-075030.txt : 20230627 0001104659-23-075030.hdr.sgml : 20230627 20230627084524 ACCESSION NUMBER: 0001104659-23-075030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230626 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENTSUR RON CENTRAL INDEX KEY: 0001251213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 231044158 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVE STREET 2: 20TH FL CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 tm2319737-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-26 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001251213 BENTSUR RON C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 1 1 1 0 Chairman & CEO 0 Common Stock 2023-06-26 4 P 0 750 16.50 A 3230779 D Includes 426,759 shares of restricted stock. /s/ Ron Bentsur 2023-06-27